Why Stripe Banned My Peptide Store (And What to Do Next)

You wake up, check your Stripe dashboard, and there it is. An email telling you your account has been "restricted" or "closed" due to a violation of their acceptable use policy. Your funds? Held for 90 to 180 days. Your customers? Can't checkout. Your revenue? Gone overnight.

If you're selling peptides online, this isn't a question of if — it's when. And the worst part is that nobody tells you this when you sign up.

Why Stripe Bans Peptide Merchants

Let's get the core issue out of the way: Stripe doesn't hate your business. They just aren't built for it.

Stripe's restricted businesses list doesn't mention "peptides" by name. Instead, they prohibit products that fall into grey-area regulatory categories — research chemicals, unapproved pharmaceuticals, and nutraceuticals that make health-related claims. Peptides get swept up in that net regardless of whether you're running a clean operation.

Here's how the detection actually works. Stripe's automated systems continuously scan your product pages, transaction descriptions, and metadata for trigger words. Compound names like BPC-157, TB-500, CJC-1295, ipamorelin, and PT-141 all raise flags. So do phrases like "research chemical," "not for human consumption," and even "laboratory use only" when they appear alongside a shopping cart.

If you're on Shopify, the situation compounds further. Shopify Payments runs on Stripe under the hood. When Stripe's algorithms detect a flagged product category, the alert goes directly to Shopify's Trust and Safety team. Some stores get terminated on day one. Others run for months before the hammer drops. Running for a while without issues doesn't mean you're safe — it just means the scan hasn't caught up yet.

What About PayPal and Square?

Same story, different logo. PayPal's acceptable use policy restricts "certain drugs and drug paraphernalia" and leaves enough ambiguity to classify research peptides however they see fit. Square's prohibited list includes "pharmaceuticals and other products that require a prescription." None of these platforms have underwriting teams familiar with the peptide industry, so the default response is always decline and terminate.

The pattern is predictable: you sign up, you process for a few weeks (maybe even months), and then one morning your funds are frozen and your account is gone. Some merchants try setting up a second account — that's a terrible idea. Stripe shares data across accounts, and opening a new one after termination can flag your business for the MATCH list (formerly the TMF), which is essentially a blacklist shared across the entire payment processing industry.

Your Funds Are Frozen — Now What?

First, take a breath. Then deal with the practical stuff.

Check your email from Stripe carefully. They'll tell you how long the reserve hold is — typically 90 to 180 days. This isn't negotiable. Stripe holds these funds to cover potential chargebacks from transactions you've already processed. Calling support or writing angry emails won't speed this up.

Don't open a new Stripe account. Seriously. They use identity verification, device fingerprinting, and business entity matching. Getting caught means the hold on your funds could extend, and you risk MATCH list placement.

Document everything. Save your transaction history, customer records, and any correspondence. You'll need this when applying for a proper peptide merchant account — underwriters at high-risk acquiring banks want to see clean processing history.

Contact your customers. Let them know you're switching payment providers. Most will be understanding — peptide customers are used to this happening with their favourite suppliers. Send them a direct link to your new checkout once it's live.

Where Peptide Merchants Actually Get Approved

The answer isn't another mainstream processor. The answer is a high-risk payment processor that has direct relationships with acquiring banks willing to underwrite peptide merchants.

There's a meaningful difference between a processor that reluctantly takes on high-risk merchants and one that's built its portfolio around them. The banks we work with have dedicated underwriting teams who understand the difference between research peptides, cosmetic peptides, and therapeutic applications. They're not going to shut you down because an algorithm flagged "BPC-157" on your product page.

What does a proper peptide merchant account look like?

• Visa and Mastercard acceptance through a bank that's pre-approved your product category
• Stable processing — no surprise terminations at the 90-day mark
• Transparent reserves — typically 5-10% rolling, with reductions over time
• Chargeback prevention tools — Ethoca alerts, Verifi CDRN, and 3D Secure built in
• A dedicated account manager who knows your vertical

Yes, the rates are higher than Stripe's 2.9% + $0.30. Expect somewhere between 3.5% and 6% depending on your volume and risk profile. But consider the alternative: Stripe at 2.9% for three months followed by a six-month fund freeze and zero revenue is a much more expensive proposition.

The MATCH List: Why Getting Banned Matters Long-Term

This is the part most merchants don't think about until it's too late. When a processor terminates your account, they can report you to the MATCH list — a database maintained by Mastercard and used by virtually every acquiring bank in the world. Being on MATCH doesn't mean you can never process again, but it makes underwriting significantly harder and more expensive.

The 2026 update to Mastercard's BRAM (Business Risk Assessment and Mitigation) program has tightened enforcement specifically around research peptides and nutraceuticals. Acquirers that were borderline comfortable with peptide merchants in previous years are now applying stricter standards, and aggregator terminations from Stripe and PayPal are more likely to trigger MATCH placement than before.

This is why moving to a proper high-risk processor before you get terminated is so important. Prevention beats recovery every time.

How to Avoid Getting Banned Again

Once you've secured a proper peptide merchant account, there are a few things you should be doing to protect it:

Keep your chargeback ratio below 1%. Visa's VAMP program tightened its merchant threshold to 1.5% in April 2026, but most acquirers enforce internal caps closer to 1%. Our chargeback prevention guide covers the specifics.

Use clear billing descriptors. "PEPTIDELABCO" on a credit card statement confuses customers. Confused customers file chargebacks. Make sure your descriptor clearly reflects your business name.

Ship fast and communicate often. Order confirmation emails, tracking numbers, and delivery updates dramatically reduce "where's my order?" disputes.

Don't make health claims. Stick to "for research purposes only" language consistently across your entire site. The moment you start talking about therapeutic benefits for human consumption, you're creating regulatory risk that makes underwriters nervous.